Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans
Author(s) -
Daniel G. MacArthur,
Jane T. Seto,
Joanna M. Raftery,
Kate G.R. Quinlan,
Gavin Huttley,
Jeff Hook,
Frances A. Lemckert,
Anthony J. Kee,
Michael R. Edwards,
Yemima Berman,
Edna C. Hardeman,
Peter W. Gunning,
Simon Easteal,
Nan Yang,
Kathryn N. North
Publication year - 2007
Publication title -
nature genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 18.861
H-Index - 573
eISSN - 1546-1718
pISSN - 1061-4036
DOI - 10.1038/ng2122
Subject(s) - biology , skeletal muscle , allele , gene , genetics , endocrinology , medicine
More than a billion humans worldwide are predicted to be completely deficient in the fast skeletal muscle fiber protein alpha-actinin-3 owing to homozygosity for a premature stop codon polymorphism, R577X, in the ACTN3 gene. The R577X polymorphism is associated with elite athlete status and human muscle performance, suggesting that alpha-actinin-3 deficiency influences the function of fast muscle fibers. Here we show that loss of alpha-actinin-3 expression in a knockout mouse model results in a shift in muscle metabolism toward the more efficient aerobic pathway and an increase in intrinsic endurance performance. In addition, we demonstrate that the genomic region surrounding the 577X null allele shows low levels of genetic variation and recombination in individuals of European and East Asian descent, consistent with strong, recent positive selection. We propose that the 577X allele has been positively selected in some human populations owing to its effect on skeletal muscle metabolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom